Study: 1 in 5 U.S. Pharmacies Blocks Access to Key Opioid Addiction Treatment

A new study reveals one in five U.S. pharmacies refuse to dispense buprenorphine, just as the Biden administration eases guidelines for prescribing the crucial addiction treatment drug.

“Buprenorphine is a vital, lifesaving medication for people with opioid use disorder, but improving access has been a problem for a variety of reasons,” said the study’s senior author, Daniel Hartung. He is a professor at Oregon Health & Science University/Oregon State University College of Pharmacy.

For the new study, Hartung and his colleagues called more than 900 pharmacies around the United States last May and June, focusing on 473 counties with high rates of death from opioid-related overdoses.

Read more:

You May Also Like…


Submit a Comment

Your email address will not be published. Required fields are marked *